期刊文献+

晨尿蛋白/尿肌酐比值和24h尿蛋白定量的相关性分析 被引量:2

The correlation between first morning urine protein-creatinine ratio and 24-hour urine protein excretion
下载PDF
导出
摘要 目的探讨晨尿蛋白/尿肌酐比值可否替代24h尿蛋白定量,监测尿蛋白的排泄情况。方法选取住院肾脏病患者136例,共272例尿标本,将晨尿蛋白/尿肌酐与24h尿蛋白定量进行相关性分析;采用ROC曲线分析确定晨尿蛋白/尿肌酐比值相对于24h尿蛋白定量分别大于0.15g、1.00g和3.00g的最佳诊断点。结果晨尿蛋白/尿肌酐比值与24h尿蛋白定量呈显著正相关(r=0.83,P〈0.01);24h尿蛋白定量≥0.15g、1.00g和3.00g时,临床诊断敏感性和特异性最佳点分别为晨尿蛋白/尿肌酐比值≥0.20g/gcr,≥0.95g/ger和≥2.92g/gcr。结论晨尿蛋白/尿肌酐比值可替代24h尿蛋白定量,监测肾脏病患者尿蛋白排泄情况。 Objective To evaluate the clinical application of total protem-to-creatmme rano m first morning urine specimens as a predictor of urine protein excretion in 24-hour collections. Methods One hundred and thirty-six specimens of 24-hour urine collection and first morning urine specimens from 136 inpatients were collected. The correlations between protein-to-creatinine ratio in first morning urine specimens and urinary protein excretion in 24-hour collections were analyzed. The cutoff values of protein-to-creatinine ratio in first morning urine specimens for screening urinary protein excretion of 0. 15 g, 1.00 g and 3.00 g in 24-hour collection were determined by receiver operating characteristics (ROC) curve. Results There was a significant positive correlation between the urinary protein excretion in 24-hour collections and protein-to-creatinine ratio in first morning urine specimens. When urine protein excretion in 24-hour collections was ≥0. 15 g, ≥1.00 g and ≥3.00 g, the corresponding protein-to-creatinine ratio for best sensitivity and specificity of clinical diagnosis was ≥0. 20 g/gcr, ≥0. 95 g/gcr and ≥2. 92 g/gcr respectively. Conclusion The protein-to-creatinine ratio in first morning urine samples can used as an alternative to urine protein excretion in 24-hour collections to monitor the excretion of urine protein in the patients with renal diseases.
出处 《临床肾脏病杂志》 2008年第9期402-404,共3页 Journal Of Clinical Nephrology
关键词 蛋白尿 尿蛋白/尿肌酐比值 24 h尿蛋白定量 Proteinuria Protein-to-creatinine ratio 24-hour urine protein excretion
  • 相关文献

参考文献10

二级参考文献38

  • 1辛岗,王芳,王梅,焦莉莉,徐国宾,王海燕.点时间尿蛋白与尿肌酐比值检测的临床应用评价[J].中华肾脏病杂志,2005,21(5):247-250. 被引量:45
  • 2Sato A, Hayashi Ko Naruse Mo et al.Effectiveness of aldosterone blockade in patients with diabetic nepbropatby. Hypertension,2003, 41:64-68. 被引量:1
  • 3Tapia E, Franco M, Sanchez-Lozada LG,et al. Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent hypertension.Kidney Int,2003, 63: 994-1002. 被引量:1
  • 4Jafar TH, Stark PC, Schmid CH, et al.Proteinuria as a modifiable risk factor forthe progression of non-diabetic renal diseases. Kidney Int, 2001, 60: 1113-1114. 被引量:1
  • 5Morales E, Valero MA, Leon M, et al.Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis, 2003,41:319-327. 被引量:1
  • 6Chagnac A, Weinstein T, Herman M, et al. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol, 2003,14: 1480-1486. 被引量:1
  • 7Joshua M, Thurman MD, Robert W, et al. Comparative Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Blood Pressure and the Kidney. Am J Med, 2003,I 14 : 588-598. 被引量:1
  • 8Ruggenenti P, Mise N, Pisoni R, et al.Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies. Circulation, 2003, 107:586-592. 被引量:1
  • 9Luis M, Ruilope MD, Julian Segura MD.Losartan and Other Angiotensin II Antagonists for Nephropathy in Type 2 Diabetes Mellitus: A Review of the Clinical Trial Evidence. Clinical therapeutics,2003, 25 :3044-3064. 被引量:1
  • 10Cupisti A, Rizza GM, D' Alessandro C,et al. Effect of telmisartan on the proteinuria and circadian blood pressure profile inchronic renal patients. Biomedicine Pharmacotherapy,2003, 57:169-172. 被引量:1

共引文献62

同被引文献14

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部